Cloning & Mutagenesis Market by Product (Cloning Kits, Mutagenesis Kits), Technology (Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-directed Mutagenesis, and Others), End User (Biopharmaceutical and Pharmaceutical Companies, CROs and CMOs, Academic and Research Institutes), and Region 2025-2033

Cloning & Mutagenesis Market by Product (Cloning Kits, Mutagenesis Kits), Technology (Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-directed Mutagenesis, and Others), End User (Biopharmaceutical and Pharmaceutical Companies, CROs and CMOs, Academic and Research Institutes), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A8110

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global Cloning & Mutagenesis Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Global Cloning & Mutagenesis Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Global Cloning & Mutagenesis Market - Breakup by Product
6.1 Cloning Kits

6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2025-2033)
6.2 Mutagenesis Kits
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2025-2033)
6.3 Attractive Investment Proposition by Product

7 Global Cloning & Mutagenesis Market - Breakup by Technology
7.1 Topo PCR Cloning

7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2025-2033)
7.2 Blunt End Cloning
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2025-2033)
7.3 Seamless Cloning
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2019-2024)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2025-2033)
7.4 Site-directed Mutagenesis
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2019-2024)
7.4.3 Market Segmentation
7.4.4 Market Forecast (2025-2033)
7.5 Others
7.5.1 Historical and Current Market Trends (2019-2024)
7.5.2 Market Forecast (2025-2033)
7.6 Attractive Investment Proposition by Technology

8 Global Cloning & Mutagenesis Market - Breakup by End User
8.1 Biopharmaceutical and Pharmaceutical Companies

8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Segmentation
8.1.4 Market Forecast  (2025-2033)
8.2 CROs and CMOs
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Segmentation
8.2.4 Market Forecast  (2025-2033)
8.3 Academic and Research Institutes
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2019-2024)
8.3.3 Market Segmentation
8.3.4 Market Forecast  (2025-2033)
8.4 Attractive Investment Proposition by End User

9 Global Cloning & Mutagenesis Market – Breakup by Region
9.1 North America
9.1.1 United States

9.1.1.1 Market Drivers
9.1.1.2 Historical and Current Market Trends (2019-2024)
9.1.1.3 Market Breakup by Product
9.1.1.4 Market Breakup by Technology
9.1.1.5 Market Breakup by End User
9.1.1.6 Key Players
9.1.1.7 Market Forecast (2025-2033)
9.1.2 Canada
9.1.2.1 Market Drivers
9.1.2.2 Historical and Current Market Trends (2019-2024)
9.1.2.3 Market Breakup by Product
9.1.2.4 Market Breakup by Technology
9.1.2.5 Market Breakup by End User
9.1.2.6 Key Players
9.1.2.7 Market Forecast (2025-2033)
9.2 Europe
9.2.1 Germany

9.2.1.1 Market Drivers
9.2.1.2 Historical and Current Market Trends (2019-2024)
9.2.1.3 Market Breakup by Product
9.2.1.4 Market Breakup by Technology
9.2.1.5 Market Breakup by End User
9.2.1.6 Key Players
9.2.1.7 Market Forecast (2025-2033)
9.2.2 France
9.2.2.1 Market Drivers
9.2.2.2 Historical and Current Market Trends (2019-2024)
9.2.2.3 Market Breakup by Product
9.2.2.4 Market Breakup by Technology
9.2.2.5 Market Breakup by End User
9.2.2.6 Key Players
9.2.2.7 Market Forecast (2025-2033)
9.2.3 United Kingdom
9.2.3.1 Market Drivers
9.2.3.2 Historical and Current Market Trends (2019-2024)
9.2.3.3 Market Breakup by Product
9.2.3.4 Market Breakup by Technology
9.2.3.5 Market Breakup by End User
9.2.3.6 Key Players
9.2.3.7 Market Forecast (2025-2033)
9.2.4 Italy
9.2.4.1 Market Drivers
9.2.4.2 Historical and Current Market Trends (2019-2024)
9.2.4.3 Market Breakup by Product
9.2.4.4 Market Breakup by Technology
9.2.4.5 Market Breakup by End User
9.2.4.6 Key Players
9.2.4.7 Market Forecast (2025-2033)
9.2.5 Spain
9.2.5.1 Market Drivers
9.2.5.2 Historical and Current Market Trends (2019-2024)
9.2.5.3 Market Breakup by Product
9.2.5.4 Market Breakup by Technology
9.2.5.5 Market Breakup by End User
9.2.5.6 Key Players
9.2.5.7 Market Forecast (2025-2033)
9.2.6 Others
9.2.6.1 Historical and Current Market Trends (2019-2024)
9.2.6.2 Market Forecast (2025-2033)
9.3 Asia Pacific
9.3.1 China

9.3.1.1 Market Drivers
9.3.1.2 Historical and Current Market Trends (2019-2024)
9.3.1.3 Market Breakup by Product
9.3.1.4 Market Breakup by Technology
9.3.1.5 Market Breakup by End User
9.3.1.6 Key Players
9.3.1.7 Market Forecast (2025-2033)
9.3.2 Japan
9.3.2.1 Market Drivers
9.3.2.2 Historical and Current Market Trends (2019-2024)
9.3.2.3 Market Breakup by Product
9.3.2.4 Market Breakup by Technology
9.3.2.5 Market Breakup by End User
9.3.2.6 Key Players
9.3.2.7 Market Forecast (2025-2033)
9.3.3 India
9.3.3.1 Market Drivers
9.3.3.2 Historical and Current Market Trends (2019-2024)
9.3.3.3 Market Breakup by Product
9.3.3.4 Market Breakup by Technology
9.3.3.5 Market Breakup by End User
9.3.3.6 Key Players
9.3.3.7 Market Forecast (2025-2033)
9.3.4 South Korea
9.3.4.1 Market Drivers
9.3.4.2 Historical and Current Market Trends (2019-2024)
9.3.4.3 Market Breakup by Product
9.3.4.4 Market Breakup by Technology
9.3.4.5 Market Breakup by End User
9.3.4.6 Key Players
9.3.4.7 Market Forecast (2025-2033)
9.3.5 Australia
9.3.5.1 Market Drivers
9.3.5.2 Historical and Current Market Trends (2019-2024)
9.3.5.3 Market Breakup by Product
9.3.5.4 Market Breakup by Technology
9.3.5.5 Market Breakup by End User
9.3.5.6 Key Players
9.3.5.7 Market Forecast (2025-2033)
9.3.6 Indonesia
9.3.6.1 Market Drivers
9.3.6.2 Historical and Current Market Trends (2019-2024)
9.3.6.3 Market Breakup by Product
9.3.6.4 Market Breakup by Technology
9.3.6.5 Market Breakup by End User
9.3.6.6 Key Players
9.3.6.7 Market Forecast (2025-2033)
9.3.7 Others
9.3.7.1 Historical and Current Market Trends (2019-2024)
9.3.7.2 Market Forecast (2025-2033)
9.4 Latin America
9.4.1 Brazil

9.4.1.1 Market Drivers
9.4.1.2 Historical and Current Market Trends (2019-2024)
9.4.1.3 Market Breakup by Product
9.4.1.4 Market Breakup by Technology
9.4.1.5 Market Breakup by End User
9.4.1.6 Key Players
9.4.1.7 Market Forecast (2025-2033)
9.4.2 Mexico
9.4.2.1 Market Drivers
9.4.2.2 Historical and Current Market Trends (2019-2024)
9.4.2.3 Market Breakup by Product
9.4.2.4 Market Breakup by Technology
9.4.2.5 Market Breakup by End User
9.4.2.6 Key Players
9.4.2.7 Market Forecast (2025-2033)
9.4.3 Others
9.4.3.1 Historical and Current Market Trends (2019-2024)
9.4.3.2 Market Forecast (2025-2033)
9.5 Middle East and Africa
9.5.1 Market Drivers
9.5.2 Historical and Current Market Trends (2019-2024)
9.5.3 Market Breakup by Product
9.5.4 Market Breakup by Technology
9.5.5 Market Breakup by End User
9.5.6 Market Breakup by Country
9.5.7 Key Players
9.5.8 Market Forecast  (2025-2033)
9.6 Attractive Investment Proposition by Region

10   Global Cloning & Mutagenesis Market – Competitive Landscape
10.1 Overview
10.2 Market Structure
10.3 Market Share by Key Players
10.4 Market Player Positioning
10.5 Top Winning Strategies
10.6 Competitive Dashboard
10.7 Company Evaluation Quadrant

11 Profiles of Key Players
11.1 ABM Industries Inc

11.1.1 Business Overview
11.1.2 Products Offered
11.1.3 Business Strategies
11.1.4 Financials
11.1.5 SWOT Analysis
11.1.6 Major News and Events
11.2 Agilent Technologies Inc.
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Business Strategies
11.2.4 Financials            
11.2.5 SWOT Analysis
11.2.6 Major News and Events
11.3 Assay Genie Limited
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
11.4 Bio-Rad Laboratories Inc.
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Business Strategies
11.4.4 SWOT Analysis 
11.4.5 Major News and Events
11.5 Charles River Laboratories International Inc. (Bausch & Lomb)
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Business Strategies
11.5.4 Financials
11.5.4 SWOT Analysis
11.5.5 Major News and Events
11.6 Genewiz Inc (Azenta Life Sciences)
11.6.1 Business Overview
11.6.2 Products Offered
11.6.3 Business Strategies
11.6.4 SWOT Analysis
11.6.5 Major News and Events
11.7 Jena Bioscience GmbH
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Business Strategies
11.7.5 SWOT Analysis        
11.7.6 Major News and Events
11.8 Merck KGaA
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Business Strategies
11.8.4 Financials
11.8.5 SWOT Analysis
11.8.6 Major News and Events
11.9 New England Biolabs Inc 
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Business Strategies
11.9.4 SWOT Analysis
11.9.5 Major News and Events
11.10 Promega Corporation 
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Business Strategies
11.10.4 SWOT Analysis
11.10.5 Major News and Events
11.11 Takara Bio Inc.
11.11.1 Business Overview
11.11.2 Products Offered
11.11.3 Business Strategies
11.11.4 Financials
11.11.5 SWOT Analysis            
11.11.6 Major News and Events
11.12 Thermo Fisher Scientific Inc.
1112.1 Business Overview
11.12.2 Products Offered
11.12.3 Business Strategies
11.12.4 Financials
11.12.5 SWOT Analysis
11.12.6 Major News and Events
11.13 TransGen Biotech Co. Ltd.
1113.1 Business Overview
11.13.2 Products Offered
11.13.3 Business Strategies
11.13.4 SWOT Analysis
11.13.5 Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

12 Global Cloning & Mutagenesis Market - Industry Analysis
12.1 Drivers, Restraints, and Opportunities

12.1.1    Overview
12.1.2    Drivers
12.1.3    Restraints
12.1.4    Opportunities
12.1.5    Impact Analysis
12.2   Porters Five Forces Analysis
12.2.1    Overview
12.2.2    Bargaining Power of Buyers
12.2.3    Bargaining Power of Suppliers
12.2.4    Degree of Competition
12.2.5    Threat of New Entrants
12.2.6    Threat of Substitutes
12.3 Value Chain Analysis

13 Strategic Recommendations

14 Appendix

Cloning & Mutagenesis Market by Product (Cloning Kits, Mutagenesis Kits), Technology (Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-directed Mutagenesis, and Others), End User (Biopharmaceutical and Pharmaceutical Companies, CROs and CMOs, Academic and Research Institutes), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials